SORIN BIOMEDICA SMARXT BCD VANGUARD SURFACE MODIFIED CARDIOPLEGIA SYSTEM

Heat-exchanger, Cardiopulmonary Bypass

COBE CARDIOVASCULAR, INC.

The following data is part of a premarket notification filed by Cobe Cardiovascular, Inc. with the FDA for Sorin Biomedica Smarxt Bcd Vanguard Surface Modified Cardioplegia System.

Pre-market Notification Details

Device IDK021830
510k NumberK021830
Device Name:SORIN BIOMEDICA SMARXT BCD VANGUARD SURFACE MODIFIED CARDIOPLEGIA SYSTEM
ClassificationHeat-exchanger, Cardiopulmonary Bypass
Applicant COBE CARDIOVASCULAR, INC. 14401 WEST 65TH WAY Arvada,  CO  80004
ContactShawn Riedel
CorrespondentShawn Riedel
COBE CARDIOVASCULAR, INC. 14401 WEST 65TH WAY Arvada,  CO  80004
Product CodeDTR  
CFR Regulation Number870.4240 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2002-06-04
Decision Date2002-07-02
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.